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Abstract
Over the past decade immuno-spin trapping (IST) has been used to detect and identify protein
radical sites in numerous heme and metalloproteins. To date, however, the technique has had little
application toward non-metalloproteins. In this study, we demonstrate the successful application
of IST in a system free of transition metals and present the first conclusive evidence of ·NO-
mediated protein radical formation in the HRas GTPase. HRas is a non-metalloprotein that plays a
critical role in regulating cell growth control. Protein radical formation in Ras GTPases has long
been suspected of initiating premature release of bound guanine nucleotide. This action results in
altered Ras activity both in vitro and in vivo. As described herein, successful application of IST
may provide a means for detecting and identifying radical-mediated Ras activation in many
different cancers and disease states where Ras GTPases play an important role.
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Immuno-spin trapping (IST), a technique pioneered by the Mason lab at the National
Institute of Environmental Health Sciences (NIEHS), allows for detection of protein radicals
via immunological-based techniques [1]. To date, IST has been limited in its applications
and has been used nearly exclusively to detect protein radicals in metalloproteins [1-5].
Recent efforts demonstrate IST can be used to detect protein radicals in various non-
metalloproteins [6, 7]. These studies, however, still required the active site of a separate
metalloprotein to generate the free radical oxidizing species used to produce the protein
radical on the target protein [6, 7]. Herein, we demonstrate the first successful application of
IST on a system free of transition metals and present evidence supporting transient protein
radical formation in a model Ras GTPase under conditions of nitrosative stress. These
findings may alter how we test for protein radicals in non-metalloproteins and also promotes
the practical application of IST in proteins where radical-mediated processes are suspected.
IST is a simple, yet novel, technique that consists of using an oxidizing species, such as
·NO2, to generate a protein radical. The 5,5′-dimethyl-1-pyrroline N-oxide (DMPO) spin
trap is subsequently used to trap the protein radical intermediate. As DMPO traps the protein
radical, a covalently-bound DMPO-nitroxide radical adduct is formed. This paramagnetic
species can undergo one-electron reduction to the corresponding hydroxylamine or one-
electron oxidation to the diamagnetic DMPO-nitrone. Of these redox states, only the nitrone
species is thermodynamically stable [1]. The stability of this species permits the use of
recently developed anti-DMPO antibodies to detect bound DMPO-nitrone protein adducts
using highly sensitive enzyme-linked immunosorbent assays (ELISAs) or simple Western
blotting [1]. One major advantage IST offers is the ability to detect protein radicals under
various experimental conditions on the bench top without the need for an electron spin
resonance (ESR) spectrometer. IST can also be conducted at much lower protein
concentrations than required for typical spin trapping ESR experiments (μg vs. mg
quantities). Moreover, as DMPO adduction adds ~111 Da to the molecular weight of the
protein, tandem mass spectrometry (MS/MS) approaches can be utilized to unambiguously
identify protein radical sites [3-5, 8, 9]. Perhaps the greatest advantage of immuno-spin
trapping is its suitability for detecting protein radical events in living cells (i.e., cell cultures
and/or in vivo) [10].
The HRas GTPase was chosen for the current study for two main reasons. First, numerous
studies demonstrate small free radical oxidants can alter Ras activity both in vitro and in
vivo [11-15]. Small free radical oxidants, such as nitrogen dioxide (·NO2), are hypothesized
to promote guanine nucleotide exchange through generation of a transient Ras thiyl protein
radical centered at Cys118 [12-15]. We have suggested elsewhere that electron transfer
between the thiyl protein radical and bound guanine nucleotide initiates premature release of
the nucleotide. This process can result in exchange of GTP for GDP and activation of the
Ras protein in vivo [12-15]. As seen in Figure 1, the nearest distance between the Cys118
sulfhydryl and bound GDP is ~ 7.5 Å, according to the 1CRR NMR structure [16]. Electron
transfer over such a distance is common given a suitable pathway for the transfer exists.
Currently, only indirect evidence supports thiyl radical formation of Ras Cys118 in the
presence of a free radical oxidant.
Second, Ras GTPases are considered one of the most prevalent oncoproteins in human
cancer. Mutations in Ras proteins are present at high levels in pancreatic (~90 %), colorectal
(35-45 %), and lung (~30 %) cancers [17]. Recent studies have also linked endogenous nitric
oxide (·NO), released from active endothelial nitric oxide synthase (eNOS), to enhanced
tumor initiation and maintenance in oncogenic Ras-driven pancreatic cancer [18]. Previous
in vitro studies from our lab demonstrated that S-nitrosation of Ras at Cys118 does not
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affect Ras activity [19]. These observations, suggest that thiyl radical production at Cys118,
rather than Cys118 S-nitrosation, may be a key factor for ·NO-mediated regulation of Ras
activity. We hypothesize the autoxidation product of ·NO, ·NO2, may contribute to Ras
activation during eNOS-enhanced pancreatic tumorigenesis through production of a
transient Ras protein radical. Successful detection of the Ras protein radical using IST-based
approaches in vitro may lay the groundwork for future tests in cancer cell lysates and/or
animal models.
For the current study, ·NO2 oxidant was generated by autoxidation of ·NO liberated from the
compound 2-(N,N-diethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO). As
opposed to bolus addition, the slow release of ·NO from DEA/NO is expected to be more
representative of cellular ·NO production by active eNOS. As shown in Figure 2 (black
pathway) and Table 1, detection of DMPO-nitrone adducts by IST involves a multitude of
kinetic steps beginning with the autoxidation of liberated ·NO to produce ·NO2 and other
higher NO-oxides [15, 20-29]. Slow release of ·NO not only simulates active eNOS, but also
helps limit formation of the non-radical oxidant dinitrogen trioxide (N2O3) [30]. Competing
reactions (grey pathways in Figure 2), unfavorable reaction rates, and low-yields of DMPO
adduction highlight the challenge of applying IST in non-metalloproteins. The reactions and
associated kinetic parameters for all pathways are listed in Table 1.
As previously stated, IST has traditionally been used to detect protein radicals in heme
proteins. The high oxidation potential of the compound I π-cation radical, formed post
addition of H2O2, drives protein radical formation and DMPO-nitroxide adduction in heme
proteins, such as myoglobin (Mb) [1]. The high-valence oxoferryl (FeIV=O) compound II
intermediate then serves as a second oxidizing equivalent to further oxidize the DMPO-
nitroxide to the DMPO-nitrone. This zwitterionic DMPO-nitrone species acts as the specific
epitope recognized by the anti-DMPO antibodies [1-5, 8, 9]. Needless to say, it becomes
difficult to match the efficiency of DMPO adduction and nitrone conversion observed in
heme proteins to that of a non-metalloprotein, such as HRas.
Material and Methods
Protein Expression and Purification
All studies were conducted using a truncated form of human HRas (1-166), which lacks the
C-terminal hyper-variable region. Previous studies have shown that the C-terminus of HRas
is unstructured and its deletion does not affect nucleotide binding, release, or hydrolysis
[31]. While removal of the hyper-variable region does not affect activity in vitro, it is
required for posttranslational lipid modification and membrane localization in vivo [32]. As
lipid modification does not occur in E. coli, inclusion of this region could lead to the
exposure and potential oxidation of cysteines near the C-terminus that does not normally
occur. HRas (1-166) was inserted into the pQLinkH vector containing a cleavable 6X N-
terminal His-tag [33] and transformed into BL21 (DE3)-RIPL E. coli cells (Stratagene). The
RIPL cells were used to supplement tRNAs for poorly expressed E. coli codons. The cells
were plated onto LB agar plates containing 100 μg/mL ampicillin (Amp) and allowed to
grow overnight at 37 °C. Colonies were isolated and a 250 mL LB broth (100 μg/mL Amp)
starter growth was allowed to grow overnight at 37 °C with shaking. Twenty mL of the
starter growth were then added to 1 L of LB broth (100 μg/mL Amp) and grown at 37 °C
with shaking until an OD600 of 0.5 was reached. Isopropyl β-D-1-thiogalactopyranoside
(IPTG) was added to a final concentration of 1 mM and the cells were grown for an
additional 18 hrs at 18 °C before collection via centrifugation. Resuspension of the cells in
lysis buffer (50 mM Hepes, 150 mM NaCl, 10 mM imidazole, 5 mM MgCl2, 100 μM tris(2-
carboxyethyl)phosphine (TCEP), 50 μM GDP, pH 7.75) was performed prior to sonication
using a Fisher Scientific 550 Sonic Dismembrator. Centrifugation was used to separate
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soluble HRas from cell debris. Soluble HRas was loaded onto a Ni-NTA agarose column
(Qiagen), treated with wash buffer (50 mM Hepes, 1 M NaCl, 20 mM imidazole, 5 mM
MgCl2, 100 μM TCEP, 50 μM GDP, pH 7.75), and eluted using elution buffer (50 mM
Hepes, 150 mM NaCl, 300 mM imidazole, 5 mM MgCl2, 100 μM TCEP, 50 μM GDP, pH
7.75). The 6X His-tag was cleaved from purified HRas by overnight incubation with 6X
His-tagged tobacco etch virus (TEV) protease (~2-3 mg/mL) at 4 °C. His-tagged TEV was
removed by a second pass through a Ni-NTA agarose column. The concentration of GDP-
bound Ras was determined using Abs280 with a molar absorptivity of 13530 M−1 cm−1. The
final yield of purified HRas was found to be ~18 mg/L broth with purity greater than 95 %
as determined by SDS-PAGE.
Immuno-spin Trapping Experiments
For the immuno-spin trapping experiments, F28L (1-166), or F28L/C118S HRas (1-166),
were exchanged and concentrated using chelexed 100 mM potassium phosphate (pH 7.4)
buffer containing 5 mM MgCl2, 50 μM GDP, and 25 μM diethylene triamine pentaacetic
acid (DTPA). In addition, 100 mM DMPO and 0.25 - 1 mM DEA/NO were added to ~350
μM protein (500 μL total volume) and reactions were allowed to proceed for 2-10 mins at
37 °C in 1.5 mL closed Eppendorf tubes. After the brief incubation at 37 °C, the Eppendorf
tubes were un-capped and the samples were exposed to open air at 25 °C for 1 hr. The
samples were diluted to ~20 μM in H2O, and SDS-PAGE was performed under non-
reducing conditions (i.e., no β-mercaptoethanol present in the loading buffer).
Electrophoretic transfer to a nitrocellulose membrane (12 V, 1 hr) was performed using a
Genie blotter (Idea Scientific) prior to overnight blocking using 4% fish gelatin in phosphate
buffered saline (PBS; pH 7.4). The blot was washed for 2 min in wash buffer (0.2 % fish
gelatin, 0.05 % Tween in PBS, pH 7.4) before being subjected to 1 hr treatment with 1 :
5000 rabbit polyclonal anti-DMPO antibodies in wash buffer [2]. The membrane was
subsequently washed for 5 min 4X in wash buffer and treated with alkaline phosphatase
conjugated anti-rabbit IgG (1 : 5000) for 1 hr. After a second 4X wash, the membrane was
treated with 5 mL of pH 9.6 TRIS buffered saline (TBS) containing CDP-Star (50 μL,
Roche) and Tropix Nitro-Block II™ (250 μL, Applied Biosystems). The resulting
chemiluminescent product was captured using radiographic film. Band intensities of SDS-
PAGE and Western blots were quantified using ImageJ software.
MS Data Collections
Acquisition of MS data were performed using a hybrid Qe-Fourier Transform Ion Cyclotron
Resonance Mass Spectrometer equipped with a 12.0 Tesla actively shielded magnet (12.0 T
AS, Apex Qe-FTICR-MS, Bruker Daltonics, Billerica, MA, USA) and an Apollo II
microelectrospray (μESI) source. The voltages on the μESI spray capillary, spray shield,
capillary exit, deflector, ion funnel and skimmer were set at +4.2 kV, +3.6 kV, +340 V,
+310 V, +185 V, and +25 V, respectively. Temperature of the μESI source was maintained
at 180 °C. Desolvation was carried out using a nebulization gas flow (2.0 bar) and a
countercurrent drying gas flow (4.5 L/s). HRas samples were prepared by re-suspending
lyophilized protein in a mixture of acetonitrile/water/acetic acid (49.0 : 49.0 : 2.0 v/v/v) at a
concentration of ~0.2 μg/μL. The samples were directly infused using a syringe pump
(Harvard Apparatus, Holliston, MA, USA) and a 100 μL syringe (Hamilton, Reno, NV,
USA), and electrosprayed at an infusion flow rate of 120 μL/hr. Before transfer, ion packets
were accumulated inside the collision cell for 1.0 second, and 100 scans per spectrum were
acquired in the ICR cell with a resolution of 580,000 at m/z 400 Da.
The primary method used to characterize the site of Ras DMPO adduction was Fourier
transform ion cyclotron resonance mass spectrometry (FTICR-MS) coupled with electron-
capture dissociation capability (ECD-MS/MS). Precursor ions of HRas were isolated in a
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quadrupole (Q1) and subjected to ECD-MS/MS in the ICR cell directly. A precursor ion
isolation window width was fixed at 2.0 Da on the ion packets that were accumulated inside
the collision cell for 10 seconds. Low energy electrons were generated by the heated hollow
dispenser cathode with a bias voltage of -2.5 V, and the ECD lens voltage was set at +15.0
V. The electrons, produced by the hollow dispenser cathode (operated at 1.7 A), were pulsed
into the ICR cell for a period of 3.0 ms, which led to dissociation of the precursor protein
ions that were trapped in the ICR cell. To maximize the ion population before irradiation,
the ICR cell was filled with 5 iterations of ion accumulation from the external collision cell,
and 100 MS/MS scans per spectrum were acquired with a resolution of 580,000 at m/z 400
Da.
Results
Immuno-spin trapping allows for detection of protein radicals via immunological-based
techniques. However, the technique has been used almost exclusively for detection of
protein radicals in metalloproteins. Herein, we employed IST to detect thiyl radical
formation in the non-metalloprotein HRas. In an effort to overcome competing reactions
(Figure 2, grey pathways) and enhance HRas protein radical detection, two adjustments
were made in our experimental design. First, a phenylalanine-to-leucine point mutation was
introduced at site 28 in our HRas (1-166) construct. The F28L mutation destabilizes
nucleotide binding and results in faster rates of intrinsic guanine nucleotide dissociation in
both HRas and Cdc42 (a Ras-related GTPase) [13, 34-36]. Structural studies indicate this
mutation creates small perturbations that are localized to the nucleotide binding site and
does not alter the secondary structure of the protein [34-36]. Given the critical role of
Cys118 in ·NO-mediated Ras guanine nucleotide exchange [11, 12], we anticipate that
treatment of wt Ras with ·NO2 will initially generate a thiyl radical. Electron transfer
between the thiyl radical and guanine nucleotide base will be extremely fast and ultimately
limits our ability to detect Ras thiyl radical formation. The faster rate of intrinsic nucleotide
exchange implies a decrease in the amount of bound nucleotide available for electron
transfer events. We, therefore, anticipate this mutant will enhance the lifetime of the Ras
thiyl protein radical and increase our ability to trap the species. Second, to facilitate the
reaction between HRas and ·NO2, relatively high concentrations of protein were used (~350
μM). The reaction kinetics associated with the HRas IST experiments are listed in Table 1.
HRas, containing a cysteine-to-serine point (C118S) mutation, was used as a negative
control for the IST experiments. This mutation does not alter the structure or biochemical
properties of Ras and has used been extensively as a negative control for numerous studies
of Ras involving reactive nitrogen species [15]. For the IST reactions, buffered F28L and
F28L/C118S HRas (1-166) were allowed to react with varying concentrations of DEA/NO
and DMPO in an open reaction vial for 1 hr. Best results were obtained when reacting ~350
μM protein with 1 mM DEA/NO and 100 mM DMPO in chelexed phosphate buffer (pH
7.4). The F28L HRas immunoblot obtained post-reaction using an anti-DMPO polyclonal
antibody, and its corresponding SDS-PAGE gel, is shown in Figure 3. Treatment of F28L
HRas with sub-stoichiometric to ~3-fold excess DEA/NO resulted in increasing amounts of
Ras-DMPO nitrone adducts. In the absence of DEA/NO, Ras-DMPO adducts were not
observed. These analyses were performed in triplicate with comparable results in each run.
Quantification of the Western band intensities in Figure 3 show that addition of 0.25 mM
and 0.5 mM DEA/NO yields bands that are 13.8 and 36.4 % the respective intensity of the 1
mM DEA/NO band. While DEA/NO concentration greatly affects the Western band
intensity, only a 6.5 % relative standard deviation (% RSD) is observed in the SDS-PAGE
band intensities for the 1, 0.5, 0.25, and 0 mM DEA/NO samples. As seen in Figure 3, the
disparity between Ras-DMPO adduction and the positive control horse heart myoglobin
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(HHMb) is significant although the concentration of Ras in the blot is over 3-fold higher
than that of HHMb (3.2 μg Ras/lane; 1 μg HHMb/lane). Densitrometry quantification
corroborates these observations as the SDS-PAGE band intensity of the HHMb control was
found to be 71 % less intense than the average of the Ras SDS-PAGE bands. As discussed in
the introduction, IST is much more efficient for heme proteins, like HHMb, due to the high
oxidation potential of the reactive compound I intermediate formed after addition of H2O2.
Therefore, a much higher concentration of the positive control HHMb-DMPO adduct is to
be expected.
To establish ·NO2 as a one-electron oxidation source, we performed the reaction under
identical conditions (~350 μM protein, 100 mM DMPO, pH 7.4) in a sealed, deoxygenated
reaction vial containing ·NO2 (g) at ~30:1 excess over Ras. Samples exposed to ·NO2 (g)
gave rise to observable Ras-DMPO adducts in the subsequent immunoblot (Supporting
Information). Ras-DMPO adducts were not detected in the absence of ·NO2 (g) under
identical conditions. To determine if Ras protein radical formation is centered at redox
active Cys118, IST experiments were also conducted on a F28L/C118S HRas double
mutant. In a side-by-side comparison, F28L/C118S HRas and F28L HRas were treated with
identical concentrations of DEA/NO (1 mM) and DMPO (100 mM). DMPO adducts were
not observed in the F28L/C118S HRas samples, while positive adducts were observed in the
F28L HRas samples (Figure 4). These data were collected in duplicate with comparable
results. The % RSD for the F28L/C118S HRas bands were found to 7.4 %, while an 11.4 %
RSD was found for the F28L HRas bands in the SDS-PAGE gel.
As DMPO adduction results in a mass increase of ~111 Da, complementary MS experiments
were employed for site-specific determination of DMPO modification sites. MS experiments
on DEA/NO / DMPO treated F28L HRas (~350 μM protein, 1 mM DEA/NO, 100 mM
DMPO) were carried out using μESI FTICR-MS ECD on a Bruker Daltonics spectrometer.
FTICR-MS with ECD is a top-down mass spectrometry approach that provides sub-
nanomolar detection limits on intact proteins without the need for sample proteolysis
[37-39]. This approach was advantageous for our current effort given the expected low yield
of DMPO adduction.
According to its amino acid sequence (Supporting Information), the theoretical average
mass of F28L HRas (1-166) ([M+H]+) is 18964.2 Da. Using μESI-FTICR-MS, exact mass
measurements of DEA/NO / DMPO treated F28L HRas identified a major peak at the
theoretical average mass (18964.2 Da, with mass error < 1 ppm in the undeconvoluted
spectrum). As seen in Figure 5A, a second peak was observed that exactly matched the
theoretical average mass of F28L HRas with adduction of a single DMPO molecule
(19075.3 Da, with mass error < 1 ppm in the undeconvoluted spectrum). This second peak
displayed approximately 2 – 3 % the intensity of the non-modified F28L HRas peak and was
consistent with estimated levels of DMPO adduction observed in the IST experiments
(Figure 3).
To identify the specific DMPO adduction site(s), precursor ions (m/z 830.3 Da, 23+ charge
state) corresponding to DMPO-modified protein were isolated for top-down mass
spectrometry experiments using ECD-MS/MS (Figure 5B). Inspection of the c- and z-type
fragment ions in the ECD-MS/MS spectrum revealed +111.1 Da mass shifts in the z50, z53,
z58, and z73 ions (Figure 5B, grey). No other c- or z-type fragment ions (c3 – c35; z5 – z47)
showed mass shifts consistent with DMPO adduction (see Supporting Information for the
full ECD-MS/MS spectrum). These data indicate DMPO adduction is localized to one of the
three amino acids differentiating the z47 and z50 fragment ions (K117, C118, and D119). As
DMPO adducts were not observed in the C118S IST control experiments (Figure 4), and
because the oxidizing potential of Asp and Lys residues are very high in comparison to Cys,
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we confidently assign Cys118 as the site of DMPO adduction under our experimental
conditions (~350 μM protein, 1 mM DEA/NO, 100 mM DMPO, pH 7.4).
Discussion
This report highlights the first conclusive evidence of protein radical formation in the non-
metalloprotein HRas. A combination of IST (Figure 4) and FTICR-ECD-MS/MS (Figure 5A
and 5B) approaches confirm DMPO adduction occurs at redox active Cys118. While in vitro
IST data provide qualitative evidence of Ras protein radical formation, particularly at
Cys118, it does not eliminate the possibility of secondary protein radicals formed through
intramolecular electron transfer of the initial Cys118 thiyl radical. This hypothesis is
reasonable given the propensity of protein radicals to undergo electron transfer, sometimes
even in the presence of DMPO [4, 40, 41]. Nonetheless, the combination of IST and MS
data in this report demonstrate protein radical formation in HRas in the presence of nitric
oxide in vitro. The question remains whether or not IST will be efficient enough to detect
Ras protein radicals in cell cultures or animal models. For the current study, an F28L HRas
mutant was chosen because of its fast intrinsic guanine nucleotide exchange rate. In vivo,
Ras GTPases will interact with numerous guanine nucleotide exchange factors (GEFs) that
enhance nucleotide exchange rates. These interactions should facilitate detection of Ras
protein radical intermediates.
A caveat of using more traditional routes of protein radical detection, such as ESR, lies in
the percent of Ras-DMPO adduction. Typically ESR requires much higher protein
concentrations, particularly when spin trapping experiments are involved. This alone makes
spectroscopic techniques, like ESR, less attractive when studying proteins that are
susceptible to aggregation or precipitation at higher concentrations (> 1 mM). Moreover, a
greater emphasis is being placed on techniques that allow detection of protein radical events
in cell cultures or in vivo systems. Under typical physiological conditions, the low levels of
molecular oxygen and high reducing environment of cells would appear to be an issue for
translation of IST into a cellular context. Cancer cells, however, exhibit a well-established
altered redox environment and often contain altered levels of antioxidant enzymes, small
molecule oxidants, and small molecule antioxidants [42, 43]. Coupling the altered redox
environment with the additional stimuli of ·NO released from active eNOS may create a
scenario where trapping Ras protein radicals in cancer cells using IST becomes feasible.
Recent studies indicate that oncogenic KRas activates the phosphatidylinositol-3-kinase
(PI3K)/Akt pathway, which leads to phosphorylation of eNOS in oncogenic KRas-driven
pancreatic cancer [18]. The ·NO released from active eNOS subsequently activates
endogenous (non-mutated) H- and NRas by S-nitrosation at Cys118. Therefore, activated H-
and NRas could stimulate PI3K and may contribute to positive feedback activation of the
PI3K/Akt/eNOS pathway [44]. The importance of this cannot be understated, as the PI3K/
Akt/eNOS pathway is a primary pathway contributing to tumor maintenance in oncogenic
KRas-driven pancreatic cancer [44].
While successful detection of ·NO-mediated protein radical formation in HRas has now been
reported, the exact mechanism through which the Ras DMPO-nitroxide is oxidized to the
corresponding DMPO-nitrone remains a question. Efforts to identify the exact oxidation
mechanism will be the focus of future work. However, several critical insights are available
from this report and other previous efforts. As Williams et al. have shown, stable S-
nitrosation of HRas at Cys118 does not alter guanine nucleotide cycling and does not alter
Ras activity [19]. Rather, the causative factor of Ras activation lies in the mechanism of S-
nitrosation itself. As seen in Figure 2, S-nitrosation of Ras can occur through different
pathways. One involves a one-electron oxidation of Cys118 (via reaction with ·NO2)
followed by a radical recombination with ·NO (Figure 2, Reactions 1 and 5). Another
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involves a non-radical pathway involving attack of an electrophilic N2O3 (Figure 2,
Reaction 4). This latter scenario is unlikely given the rate of N2O3 hydrolysis is nearly an
order of magnitude greater than its reaction toward thiols [15, 24]. Therefore, a pathway
which involves a Ras Cys118 radical must be considered, given data indicating high levels
of endogenous H and NRas S-nitrosation upon activation of eNOS in KRas-driven
pancreatic cancer [18]. Successful implementation of IST to trap intermediate Ras protein
radicals during this process in vivo would greatly advance our knowledge of how ·NO
mechanistically drives Ras activation during pancreatic tumor initiation and maintenance.
Conclusion
In conclusion, we have presented direct evidence of protein radical formation in a model Ras
GTPase and confirmed DMPO adduction is centered at redox active Cys118 using immuno-
spin trapping and FTICR-MS approaches. This study also demonstrates the successful
application of IST on a non-metalloprotein where transition metals or separate
metalloproteins were not used to generate an oxidizing species. The findings may have far
reaching implications for detecting protein radical events in other non-metalloproteins, such
as phosphatases [45], caspases [46, 47] and protein kinases [48], where ·NO-mediated
processes are known to influence protein activity via redox active cysteines. The in vitro
detection of Ras GTPase protein radicals by IST, even as a proof-of-principle, also sets the
groundwork for integration of the technique in future cellular-based investigations. While
Ras GTPases are known to be mutated in numerous different cancers, including cancer of
the pancreas, colon, and lung [17], little emphasis has been placed on understanding the role
of radical-mediated Ras activation in these disease states. This remains true today, even as
evidence clearly implies a radical-mediated pathway contributes to tumor initiation and
maintenance in Ras-driven pancreatic cancer [18]. We anticipate IST may become a useful
method to test for radical-mediated Ras activation in many different cancers or disease states
where Ras GTPases play a significant role. Successful detection of Ras protein radicals in
cancer cell cultures or animal models may pave important directions toward the
development of new anti-Ras therapeutic agents targeting radical-mediated activation
pathways.
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Abbreviations
DEA/NO 2-(N,N-diethylamino)-diazenolate-2-oxide diethylammonium salt
DMPO 5,5-dimethyl-1-pyrroline N-oxide
eNOS endothelial nitric oxide synthase
FT-ICR Fourier transform ion cyclotron resonance
GAPs GTPase activating proteins
GDP guanosine-5′-diphosphate
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• Evidence of ·NO-mediated protein radical formation in HRas is presented.
• Immuno-spin trapping (IST) and tandem MS/MS indicate a Cys118 Ras protein
radical.
• IST may be used to detect thiyl radical formation in the Ras oncoprotein.
• The IST approach described can be used for other non-metalloproteins.
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Figure 1. NMR solution structure (pdb 1CRR) of GDP-bound HRas
Bound GDP and the Cys118 side chain are highlighted in sticks (Mg2+ is shown in green).
Approximately 7.5 Å separates bound GDP from the sulfhydryl on Cys118.
Davis et al. Page 13













Figure 2. Ras immuno-spin trapping reaction diagram
The black pathway shows the primary reaction steps involved in ·NO-mediated Ras
immuno-spin trapping experiments. The grey pathways highlight competing reactions
associated with the experiment. Reactions and kinetic parameters associated with all
reaction steps are shown in Table 1.
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Figure 3. Immunoblot and SDS-PAGE gel of the Ras IST experiment
Immunoblot (top) and SDS-PAGE (bottom) gels are shown for DEA/NO treated F28L HRas
in the presence of DMPO. For the IST treatment, ~350 μM of Ras was exposed to varying
concentrations of DEA/NO (0, 0.25, 0.5, and 1.0 mM) in the presence of 100 mM DMPO.
The Ras protein was allowed to react with DEA/NO and DMPO for 2-10 min at 37 °C in a
closed Eppendorf tube. After 10 min, the Eppendorf tube containing the reaction mixture
was opened and left at 25 °C for 1 hr. As the concentration of DEA/NO is increased, a
concomitant increase in the Ras-DMPO nitrone adduct is observed. For the positive control,
10 μM HHMb was treated with 100 μM H2O2 in the presence of 100 mM DMPO in a
closed Eppendorf tube at 25 °C for 1 hr. Here, 3.2 μg of Ras were loaded into each lane, and
1.0 μg of the positive HHMb control was loaded into the last lane (far right).
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Figure 4. Immunoblot and SDS-PAGE gel of an IST experiment utilizing a C118S redox-inactive
Ras mutant
Immunoblot (top) and SDS-PAGE gels (bottom) are shown comparing identical reactions of
F28L/C118S and F28L HRas using 1 mM DEA/NO and 100 mM DMPO. For both
reactions, ~350 μM of F28L/C118S and F28L HRas were exposed to 1.0 mM DEA/NO in
the presence of 100 mM DMPO. Both reactions were allowed to proceed for 2-10 min at 37
°C in a closed Eppendorf tube and for an additional 1 hr in an open Eppendorf tube at 25 °C.
For the gel and immunoblot, 3.2 μg of F28L HRas and 3.0 μg of F28L/C118S HRas were
used for loading. The F28L/C118S HRas mutant shows no evidence of DMPO adduction in
the Western blot, while treatment of F28L HRas under the same conditions results in
observable DMPO adducts (top panel).
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Figure 5. Mass spectral analysis of HRas after IST treatment
Panel A: Top-down μESI-FTICR-MS analysis (100 scans) on F28L HRas obtained post
reaction with 1 mM DEA/NO and 100 mM DMPO. Exact mass measurements of F28L
HRas identify non-modified protein (18964.2 kDa, mass error < 1 ppm in the
undeconvoluted spectrum) and DMPO-adducted F28L HRas (19075.3 kDa, mass error < 1
ppm in the undeconvoluted spectrum). The + 111.1 mass shift is consistent with the mass
addition of 1 DMPO molecule. The modified protein is observed at ~2 - 3 % the intensity of
unmodified protein. Panel B: ECD-MS/MS spectrum of the resulting mass fragments of
DMPO-modified F28L HRas. The sequence and fragmentation pattern for the z73 – z5
fragment ions is shown at the top. In the ECD-MS/MS spectrum (bottom, mass error < 1
ppm), +111.1 Da mass shifts are observed in the z50, z53, z58, and z73 fragment ions (grey)
indicating DMPO adduction only in the fragments containing Lys117, Cys118, and Asp119.
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